Clinical Trial Update: A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics, pharmacodynamics, safety and tolerability of repeated dosing of RO5459072 in volunteers with celiac disease; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• RO5459072

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Celiac Disease | Phase 1 | Status: COMPLETED